Dukic N, Gojkovic Z, Vladicic-Masic J, Masic S, Lalovic N, Popovic S. Adjuvant application of trastuzumab in HER2 positive breast cancer and impact on time to relapse. Arch Oncol [Internet]. 2019 Jul. 29 [cited 2026 Jul. 12];26(1):10-5. Available from: https://asistent.ceon.rs/index.php/aoo/article/view/AOO181112006D